Revvity's (NYSE:RVTY) Signals Software platform has joined Anthropic's Model Context Protocol directory, connecting Signals AI to Anthropic's Claude models to streamline scientific data access and analysis. This development expands how researchers interact with complex R&D datasets using AI tools, allowing Claude and Claude Science to query Signals' governed data and scientific context through natural language. The move aims to keep Revvity's tools central to how pharma and biotech teams work with R&D data, positioning the company in a market where Thermo Fisher Scientific, Danaher and Waters are all pushing their own AI-powered informatics and lab software offerings. For Revvity, the Signals MCP connector is about making its existing software footprint more useful rather than launching a new standalone product. The key questions are adoption and real-world usage; the pace at which researchers plug Signals AI into their daily work will shape how material this integration becomes. Execution risk remains, as slow or fragmented customer adoption of Claude-based workflows may not meaningfully support the software ambitions discussed in the narrative.